QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Zentalis Pharmaceuticals (ZNTL) News Today

$14.08
+0.44 (+3.23%)
(As of 02/26/2024 ET)
SourceHeadline
marketbeat.com logoPrimecap Management Co. CA Has $20.74 Million Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - February 26 at 8:48 AM
marketbeat.com logoFmr LLC Reduces Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - February 24 at 6:02 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Stake Lessened by Federated Hermes Inc.
marketbeat.com - February 23 at 8:46 AM
msn.com logoRAPT stock craters after FDA puts clinical hold on dermatitis drug
msn.com - February 20 at 12:36 PM
marketbeat.com logoZentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price Up 4.2%
marketbeat.com - February 20 at 11:56 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Position Trimmed by Rafferty Asset Management LLC
marketbeat.com - February 20 at 6:53 AM
marketbeat.com logoBarclays PLC Sells 101,598 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - February 15 at 4:44 AM
finance.yahoo.com logoDown -19.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Zentalis Pharmaceuticals, Inc. (ZNTL)
finance.yahoo.com - February 14 at 3:37 PM
morningstar.com logoZentalis Pharmaceuticals Inc Ordinary Shares
morningstar.com - February 13 at 7:34 PM
finance.yahoo.com logoZentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference
finance.yahoo.com - February 13 at 9:32 AM
finance.yahoo.com logoWhat Makes Zentalis Pharmaceuticals, Inc. (ZNTL) a New Buy Stock
finance.yahoo.com - February 8 at 6:00 PM
seekingalpha.com logoZentalis Pharmaceuticals: Azenosertib Continues To Impress
seekingalpha.com - February 7 at 6:47 AM
finance.yahoo.com logoInsider Sell: President Cam Gallagher Sells 11,552 Shares of Zentalis Pharmaceuticals Inc (ZNTL)
finance.yahoo.com - February 6 at 10:28 AM
marketbeat.com logoBank of New York Mellon Corp Has $4.86 Million Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - February 1 at 4:27 AM
finance.yahoo.com logoZentalis Pharmaceuticals Strengthens Management Team with Key Appointments
finance.yahoo.com - January 25 at 8:01 AM
marketbeat.com logoTD Asset Management Inc Increases Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - January 18 at 5:31 AM
marketwatch.com logoImmunome, Zentalis Pharmaceuticals in Licensing Agreement
marketwatch.com - January 8 at 7:40 AM
finance.yahoo.com logoImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
finance.yahoo.com - January 8 at 7:40 AM
stockhouse.com logoSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Zentalis Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - December 13 at 9:33 AM
marketbeat.com logoBoxer Capital LLC Purchases Shares of 450,000 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - December 11 at 7:39 AM
marketbeat.com logoMatrix Capital Management Company LP Boosts Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - December 10 at 9:46 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Rating of "Moderate Buy" by Analysts
marketbeat.com - December 10 at 2:16 AM
finanznachrichten.de logoZENTALIS PHARMACEUTICALS: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - December 2 at 8:18 AM
finance.yahoo.com logoDavid Johnson Bought 16% More Shares In Zentalis Pharmaceuticals
finance.yahoo.com - November 16 at 10:11 AM
seekingalpha.com logoZentalis: Latest Market Sell-Off Looks Justified With Data Catalysts Long Way Off
seekingalpha.com - November 14 at 3:14 PM
finance.yahoo.com logoDirector David Johnson's Strategic Purchase of Zentalis Pharmaceuticals Inc Shares
finance.yahoo.com - November 13 at 11:24 PM
barrons.com logoINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Zentalis Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
barrons.com - November 10 at 12:22 AM
msn.com logoWedbush Downgrades Zentalis Pharmaceuticals (ZNTL)
msn.com - November 9 at 9:21 AM
finance.yahoo.com logoZentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen
finance.yahoo.com - November 9 at 9:21 AM
msn.com logoWedbush cuts Zentalis to neutral, cites strategy shift for ovarian cancer drug
msn.com - November 8 at 2:33 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL) and Humana (HUM)
markets.businessinsider.com - November 7 at 7:36 PM
barrons.com logoINVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Zentalis Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
barrons.com - November 7 at 7:36 PM
msn.com logoZentalis hits 52-week low as Leerink downgrades on data for lead asset
msn.com - November 7 at 7:36 PM
markets.businessinsider.com logoMorgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
markets.businessinsider.com - November 7 at 2:36 PM
finance.yahoo.com logoZentalis Pharmaceuticals Inc (ZNTL) Reports Q3 2023 Financial Results and Operational Updates
finance.yahoo.com - November 7 at 12:01 AM
marketwatch.com logoZentalis Pharmaceuticals Shares Hit All-Time Low
marketwatch.com - November 6 at 2:00 PM
msn.com logoZentalis Pharmaceuticals GAAP EPS of -$0.79 beats by $0.15
msn.com - November 6 at 9:00 AM
finance.yahoo.com logoZentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
finance.yahoo.com - November 6 at 9:00 AM
morningstar.com logoZentalis Pharmaceuticals Inc Ordinary Shares ZNTL
morningstar.com - November 5 at 12:03 AM
seekingalpha.com logoCatalyst gets FDA review for higher dose of Firdapse for rare neuromuscular disorder
seekingalpha.com - October 13 at 1:35 PM
finance.yahoo.com logoInsider Sell: Chief Medical Officer Carrie Brownstein Sells 10,628 Shares of Zentalis ...
finance.yahoo.com - October 7 at 7:55 AM
marketbeat.com logoSG Americas Securities LLC Makes New Investment in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - September 22 at 4:34 AM
finance.yahoo.com logoDirector Jan Skvarka Sells 5,000 Shares of Zentalis Pharmaceuticals Inc (ZNTL)
finance.yahoo.com - September 14 at 2:19 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Stake Lessened by Wellington Management Group LLP
marketbeat.com - September 7 at 6:09 AM
finance.yahoo.com logoZentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
finance.yahoo.com - September 6 at 8:26 AM
marketbeat.com logoSectoral Asset Management Inc. Purchases 33,000 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - September 5 at 3:13 PM
marketbeat.com logoExodusPoint Capital Management LP Reduces Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
marketbeat.com - September 4 at 6:09 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Russell Investments Group Ltd.
marketbeat.com - September 1 at 4:20 AM
marketbeat.com logoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Recommendation of "Buy" by Analysts
marketbeat.com - September 1 at 2:39 AM
seekingalpha.com logoZentalis: A Buy As Small Molecule Trials Continue To Advance
seekingalpha.com - August 24 at 9:42 AM
Get Zentalis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZNTL and its competitors with MarketBeat's FREE daily newsletter.



ZNTL Media Mentions By Week

ZNTL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZNTL
News Sentiment

1.06

0.45

Average
Medical
News Sentiment

ZNTL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZNTL Articles
This Week

6

2

ZNTL Articles
Average Week

Get Zentalis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZNTL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ZNTL) was last updated on 2/26/2024 by MarketBeat.com Staff